Core Insights - Cannabix Technologies Inc. has initiated the phased commercialization of its Cannabix Marijuana Breath Test (MBT) by delivering multiple units to Omega Laboratories in Ohio, focusing on the detection of delta-9-tetrahydrocannabinol (Δ9-THC) in breath samples [1][2] Group 1: Product and Technology - The MBT hardware includes Cannabix's proprietary Breath Collection Unit (BCU) and Breath Cartridges (BC), designed for the recent use detection of Δ9-THC, unlike traditional methods that can detect THC long after consumption [1][2] - The initial shipment consists of 200 Breath Cartridges and several BCUs, supporting the integration of breath testing into Omega's lab testing protocols [2] Group 2: Partnership and Collaboration - Cannabix and Omega are collaborating to implement the MBT with select key clients and are ramping up to meet demand [2] - The partnership includes efforts in manufacturing, marketing, distribution, support, and logistics for the MBT [2] Group 3: Company Background - Omega Laboratories has over twenty years of experience in forensic drug testing and holds multiple federal and international certifications for its facility [3] - Omega's Laboratory Developed Test Method for testing Δ9-THC analytes has been validated in an ISO/IEC 17025 accredited laboratory environment [4]

Core Insights - Cannabix Technologies Inc. has developed an autonomous alcohol breathalyzer screening device aimed at various industries and safety settings [1][4] - The company has partnered with Price Industries Ltd. for the manufacturing of its BreathLogix alcohol screening device product line [1][2] - The BreathLogix "Workplace Series" device has received approval from the National Highway Traffic Safety Association to be included in the U.S. Federal Register Conforming Products List [2] - Cannabix has entered into an exclusive distribution agreement for its products in Australia, New Zealand, and the Pacific Islands [2] - The company is in discussions with manufacturers in the U.S. and Canada regarding its Marijuana Breath Testing technology [3] Company Overview - Cannabix Technologies Inc. specializes in developing marijuana and alcohol breath testing technologies for workplaces and law enforcement [4] - The focus of the breath testing technology is on detecting recent marijuana use through delta-9 THC [4] - The company aims to enhance alcohol safety and monitoring through its BreathLogix autonomous alcohol screening device [4]

Core Insights - Cannabix Technologies Inc. has entered into an exclusive distribution agreement with Breathalyser Sales & Service Pty Ltd for its BreathLogix autonomous alcohol breathalyzer devices in Australia, New Zealand, and the Pacific Islands, marking its first international distribution agreement [1][5] - The BreathLogix device is designed to rapidly check breath alcohol levels, take user photos for identity verification, and alert managers in real-time to prevent alcohol-related incidents [1][8] - The agreement is for an initial term of two years and targets industries such as mining, oil and gas, industrial, trucking, and warehousing [5] Company Overview - Cannabix Technologies Inc. specializes in developing marijuana and alcohol breath testing technologies for various settings, including workplaces and law enforcement [10] - The company is transitioning from research and development to market delivery of its innovative breath testing technologies [4] - Cannabix is also advancing its Marijuana Breath Test (MBT) alongside the BreathLogix alcohol technology, with distribution agreements established in multiple regions [5] Distribution Partner Insights - Breathalyser SSP is a leading distributor of alcohol and drug testing devices in Australia, with established product lines and a diverse client base across various sectors [2][4] - The partnership with Cannabix is expected to enhance employee safety through pre-access alcohol testing solutions [4] Product Features - BreathLogix offers features such as rapid breath alcohol testing, integration capabilities with existing systems, and cloud reporting for real-time management [4][8] - The device includes patent-pending pre-calibrated sensor cartridge technology, simplifying maintenance and reducing costs associated with calibration [9]

Core Insights - Cannabix Technologies Inc. has developed an autonomous alcohol breathalyzer screening device, BreathLogix, aimed at various industries and safety settings [1][3] - The company has entered into a non-exclusive distribution agreement with Alco Prevention Canada for the North American market [1][2] - The BreathLogix device is designed for self-testing, which can enhance workplace safety and reduce costs associated with traditional testing methods [3][5] Company Overview - Cannabix Technologies focuses on developing marijuana and alcohol breath testing technologies for workplaces and law enforcement [9] - The BreathLogix device features patent-pending pre-calibrated cartridge technology, allowing for easy maintenance without costly calibration equipment [5][6] - The device can perform various types of alcohol testing, including pre-access, random, and post-incident testing [5][6] Distribution and Market Strategy - Alco Prevention has a significant presence with 4,000 points of sale and 45 agents globally, which will aid in the distribution of BreathLogix [2] - The partnership with Alco Prevention is expected to facilitate the deployment of the BreathLogix device in safety-sensitive environments such as construction sites, bars, and restaurants [3][5] - Cannabix is in discussions with additional distributors to expand its market reach beyond North America [1]